Advanced Biomed Inc. (ADVB)
Nasdaq: ADVB · Services-Medical Laboratories · Reno, NV · filing with the SEC since 2022
Filings
98 filings since 2017 beside 1 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-Q
Quarterly report for the quarter ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Feb 14, 2027
10-K
Annual report for the fiscal year ending Jun 30, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Sep 28, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Jun 4, 2026.
Filings a yearinsider forms included
23293026
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest May 1, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Jan 21, 2026.SEC letters: 17 in the last 36 months, the newest Feb 10, 2025.A late-filing notice, Form NT 10-K, filed Sep 28, 2026.A late-filing notice, Form NT 10-Q, filed Nov 14, 2025.A late-filing notice, Form NT 10-K, filed Sep 30, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
May 1, 2026
8-K items 2.01, 3.02, 5.02, 9.01
Purchase or sale of a business completed; Shares sold without registration; Officer or director change · Current report
Apr 28, 2026
Feb 26, 2026
8-K items 3.03, 5.03, 8.01, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change; Other event · Current report
Feb 20, 2026
Feb 2, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Jan 28, 2026
Dec 30, 2025
8-K items 1.01, 2.01, 7.01, 9.01
Major agreement signed; Purchase or sale of a business completed; Investor disclosure (Regulation FD) · Current report
Dec 23, 2025
Mar 10, 2025
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Mar 5, 2025
40 of 98 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.